Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat." is generating significant coverage in the Health category, with 6 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include LADbible, AOL.com, The Sun and AFR. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 135d ago.
Quick answers
Why is "Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat." trending?
Because 6 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Woman issues warning after eyes went yellow when taking 'world's most powerful weight-loss drug' LADbible · 137d ago
- "Here for the peptides": Unapproved weight-loss drug sold at Brooklyn bodega AOL.com · 137d ago
- 'Godzilla' fat jab linked to liver damage as unlicensed drug turns users yellow The Sun · 137d ago
- The weight loss ‘quick fix’ driving a wave of hospitalisations AFR · 137d ago
- What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug CBS News · 137d ago
- Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat. The Washington Post · 137d ago
Topics
Related trends
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.
Water Fluoridation Does Not Impair Brain Function
An Irish study of 2,495 older adults found no link between lifetime exposure to fluoridated drinking water and poorer cognitive function.
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
Federal regulators issue a new warning regarding GLP-1 medications and a rare eye condition linked to sudden blindness.
US regulator orders makers of weight-loss drugs to carry blindness risk warning
The FDA is requiring all GLP-1 drug makers to add a warning about NAION, a rare eye condition that can cause sudden blindness, to their prescribing information.